#14: ACTC News Dr. Robert Lanza of Advanced Cell Technology, Inc. and His Colleagues Receive Praise for Essentials of Stem Cell Biology from The New England Journal of Medicine and Others
WORCESTER, Mass.--(BUSINESS WIRE)--July 11, 2006--Advanced Cell Technology's (OTCBB:ACTC) Robert Lanza, M.D., Vice President of Research & Scientific Development, and his colleagues continue to...
WORCESTER, Mass.--(BUSINESS WIRE)--Dec. 7, 2005--Advanced Cell Technology, Inc. (OTC BB: ACTC) will participate in the Harris Nesbitt Focus on Healthcare Conference scheduled for Thursday, December...
WORCESTER, Mass.--(BUSINESS WIRE)--Nov. 8, 2005--Advanced Cell Technology, Inc.'s (OTC BB: ACTC) VP of Medical & Scientific Development, Robert Lanza, M.D. will present at the Stem Cell Research...
WORCESTER, Mass.--(BUSINESS WIRE)--Nov. 3, 2005-- Advanced Cell's Management Team will make Company Presentation at Conference on November 7th, 2005 Advanced Cell Technology, Inc.'s...
WORCESTER, Mass.--(BUSINESS WIRE)--Oct. 27, 2005--William M. Caldwell, IV, Chief Executive Officer, along with James G. Stewart, Chief Financial Officer of Advanced Cell Technology, Inc.,...
#9: ACTC News CORRECTING AND REPLACING Advanced Cell Technology Announces Alternative Approach for Derivation of Embryonic Stem Cell Lines; Approach Maintains Developmental Potential of Embryo
WORCESTER, Mass.--(BUSINESS WIRE)--Oct. 16, 2005--The last sentence of the sixth paragraph should read Irina Klimanskaya, Sandy Becker and Young Chung of Advanced Cell Technology contributed...
WORCESTER, Mass.--(BUSINESS WIRE)--Sept. 16, 2005--Advanced Cell Technology, Inc. (OTCBB:ACTC) announced today that it has closed a private placement of convertible notes and warrants to raise...
WORCESTER, Mass.--(BUSINESS WIRE)--Sept. 9, 2005--Michael D. West, Ph.D., President and Chief Scientific Officer of Advanced Cell Technology, Inc. (OTCBB:ACTC), will present, "Human Embryonic Stem...
#6: ACTC News Robert Lanza, M.D. to Deliver a Keynote Presentation at the Biotechniques Live! / Drug Discovery Technology & Development World Congress' Annual Conference; Presentation to Highlight the Potential of Human Embryonic Stem Cell Therapies
WORCESTER, Mass.--(BUSINESS WIRE)--Aug. 10, 2005--Robert Lanza, M.D., Vice President of Medical and Scientific Development, Advanced Cell Technology, Inc., (OTCBB:ACTC) will deliver a keynote...
#5: ACTC News Advanced Cell Technology Announces New Board Member; Alan C. Shapiro, Ph.D., Brings Wealth of Corporate and International Financial Management Experience
WORCESTER, Mass.--(BUSINESS WIRE)--Aug. 5, 2005--Advanced Cell Technology, Inc. (OTCBB:ACTC) today announced that Alan C. Shapiro, Ph.D., has been elected to serve as a member of the Company's...
WORCESTER, Mass. & LA JOLLA, Calif.--(BUSINESS WIRE)--July 27, 2005--Advanced Cell Technology, Inc. (OTCBB:ACTC) announced today it has entered into a research collaboration agreement with the The...
#3: ACTC News Dr. Robert Lanza of Advanced Cell Technology Testifies Before Senate Subcommittee; Addresses Methods for Obtaining Embryonic Stem Cells and Strongly Urges Passage of the Stem Cell Research Enhancement Act of 2005
WORCESTER, Mass.--(BUSINESS WIRE)--July 12, 2005--Robert Lanza, M.D., Vice President of Medical and Scientific Development at Advanced Cell Technology, Inc. (OTCBB:ACTC), testified today before the...
Dr. Robert Lanza of Advanced Cell Technology to Testify before Senate Subcommittee; Testimony to Address Alternative Methods for Obtaining Embryonic Stem Cells: Tuesday, July 12 - Washington, DC
...
A.C.T. Holdings, Inc. Announces Name Change to Advanced Cell Technology, Inc.; Company Receives New Trading Symbol: OTCBB: ACTC
BIOWIRE2K
WORCESTER, Mass.--(BUSINESS WIRE)--June 22,...
